Introduction
Lung cancer is the leading cause of cancer death in men and women worldwide and continues to rise in frequency. Lung carcinomas are generally classified as either small-cell lung carcinoma (SCLC) or non-SCLC (NSCLC) type. Within these groups further distinctions are made, with NSCLC classified as adenocarcinoma (AC), squamous cell carcinoma (SCC), and large-cell carcinoma. After AC, SCC is the most frequent cancer histology, accounting for approximately 30% of all lung cancers. Its development is the most strongly related to inhaled carcinogens, as in cigarette smoke. For ACs, subclassification by differentiation grade (Garber et al., 2001) or histological pattern (Miyoshi et al., 2003) is useful to predict clinical outcome. For SCCs, differentiation grade is used for pathological subclassification, but it correlates poorly with prognosis. Although SCCs demonstrate some histological variation, such as with the basaloid variant, this does not allow good prediction of clinical outcome. The present system used to subclassify SCC is thus insufficient. In this study, we attempted to make a clinically useful classification based on gene expression profiling.
This latter provides a direct method of surveying gene transcription and has increased our understanding of several cancers including lung carcinomas (Bhattacharjee et al., 2001; Garber et al., 2001; Nacht et al., 2001; Miura et al., 2002; Virtanen et al., 2002; Borczuk et al., 2003; Amatschek et al., 2004; Jones et al., 2004; Kettunen et al., 2004; Tomida et al., 2004) . Here, we used microarray-based expression profiling techniques to subclassify a series of lung SCCs. Our initial analysis by using hierarchical clustering (HC) allowed division into two distinct groups (SCC-A and SCC-B). However, HC has the disadvantage that it depends largely on genes selected in the filtering process, and it is highly sensitive to the metric used to assess similarity, and typically requires subjective evaluation to define clusters. To ensure that the initial classification of SCC samples was accurate and robust, we therefore performed an additional round of HC with quite different gene filtering and consensus clustering with the nonnegative matrix factorization (NMF) approach (Lee and Seung, 1999; Brunet et al., 2004) . NMF, a novel dimensionality reduction technique, has been recently proposed to be useful for clustering expression data (Brunet et al., 2004 ). NMF appears to be more accurate and robust to the choice of input genes than HC. Furthermore, NMF can be combined with a quantitative evaluation of the robustness of the number of clusters. To our knowledge, this is the first report in which the NMF approach was adopted to confirm the robustness of a classification indicated by HC in gene expression profiling.
Results
Firstly, we wished to identify genes whose expression patterns are characteristic of SCC. A statistical comparison (Welch's ANOVA, Bonferoni correction, P ¼ 0.05) was therefore used to identify genes differentially expressed between SCC, AC, and normal lung. A set of 4689 genes was selected (see Materials and methods). Two-way HC of data for 48 SCCs, nine ACs, and 30 normal lung samples against the gene set was performed using a Pearson correlation around 0 (Figure 1a ). In the dendrogram, two major clusters were defined. The first contained all tumor samples and was further divided into three groups containing 25 SCCs, 23 SCCs, and all nine ACs. The second major cluster contained all normal lung samples.
Groups of genes whose expression patterns were characteristic of SCC were identified. A group of 1331 genes, annotated as 'Up in SCC' in Figure 1a , was commonly upregulated across all SCCs, while another group of 1458, annotated as 'Down in SCC', was commonly downregulated in all SCCs. The top 15 genes are listed in Table 1 . The top upregulated genes in SCCs included several genes encoding epithelial cell-specific markers. Keratin 5 (KRT5) and KRT14 are specifically expressed in the basal layer of the epidermis and have been reported to be overexpressed in lung SCCs (Borczuk et al., 2003; Amatschek et al., 2004; Kettunen et al., 2004) . Mutations in these genes are associated with the skin-blistering disorder, epidermolysis bullosa simplex. Besides KRT5 and KRT14, upregulated 1331 genes included many keratin gene family members (KRT6B, 12, 13, 16, 25D, KRTHA1) . Desmocollin 3 (DSC3) and desmoglein 3 (DSG3) are desmosomal family members engaged in cell adhesion. These two genes are expressed in the basal and suprabasal layers of epidermis and have been reported to be overexpressed in lung SCCs (Amatschek et al., 2004; Kettunen et al., 2004) . The top downregulated gene was caveolin-1 (CAV1), whose expression has been reported to correlate with poor prognosis of lung SCCs (Yoo et al., 2003) . The constant and marked downregulation of CAV1 might result from massive expression of CAV1 in the normal lung samples. In a recent report, CAV1 was constantly downregulated in lung cancer samples by cDNA array, but CAV1 protein expression was detected immunohistochemically in half of the samples . TTF-1 and SP-A, which are useful markers for type 2 pneumocyte differentiation, were included in the downregulated 1458 genes.
Using the EASE analysis (see Materials and methods), we identified biological process categories that showed a disproportionately high number of coregulated genes (significant over-representation in those categories). The Gene Ontology Biological Process categories over-represented by up-and downregulated Table 2 . Cell-proliferationrelated categories were mainly over-represented by upregulated genes in SCCs (e.g. transcription factor DP1). In the over-represented metabolism category, there were some genes probably involved in metabolism of tobacco carcinogens by their oxidoreductase activity (e.g. AKR1B10, C1, C3, ALDH3A1, GPX2, peroxiredoxin). Aldoketo reductase family 1, member C (AKR1C) is implicated in the conversion of polycyclic aromatic hydrocarbons into active carcinogens in lung (Palackal et al., 2002) . Overexpression of AKR1B10 appears characteristic of smokers' non-small-cell lung carcinomas (Fukumoto et al., 2005) . The over-represented ectoderm development category consisted mainly of genes involved in epidermal development (e.g. KRT5, 6B, 13, SPRR1B, KRTHA1, desmoplakin). Tumor protein p63 (TP73L), an oncogene amplified in SCC that is involved in epidermal morphogenesis (Mills et al., 1999; Yang et al., 1999; Hibi et al., 2000) , was also included. For the categories over-represented by downregulated genes in SCCs, many of them were associated with communication between cells and their surroundings. These included death-associated protein kinase 1 (DAPK1), an inducer of apoptosis through extracellular signaling (Deiss et al., 1995) . Aberrant promoter hypermethylation of DAPK is early and frequent in lung tumors induced by smoking (Esteller et al., 2001; Pulling et al., 2004) . Besides the genes that were regulated uniformly across all SCCs, a group of 432 whose expression differed between the two SCC clusters was identified and annotated as 'Different in SCC' in Figure 1a . Twoway HC of all SCCs samples against these 432 genes was performed using Euclidean distances for the sample tree and Pearson correlations for the gene tree ( Figure 1b ). This resulted in the segregation of SCCs into two clear groups of 34 (SCC-A) and 14 (SCC-B). To verify the accuracy and robustness of this classification, we performed additionally an independent round of HC and adopted the NMF approach.
For the additional independent round of HC, a group of 3891 genes that were up-or downregulated in SCC samples were selected (see Materials and methods). Two-way HC of all SCC samples was performed using a Pearson correlation around 0 (Figure 2 ). In the dendrogram, SCC-B samples formed a distinct independent cluster, except for one sample. Considering the susceptibility of HC to prior gene selection, a mostly independent cluster of SCC-B samples might indicate a certain consistency for the initial classification of SCCs (SCC-A and SCC-B). For the NMF approach (see Materials and methods), 3344 genes were selected as a set of input genes for all 48 SCC samples. Reordered consensus matrices at k ¼ 2-7 and cophenetic correlation coefficients corresponding to the HC of consensus matrices are shown in Figure 3 . As clear block diagonal patterns attest to the robust class for k ¼ 2, cophenetic correlations quantitatively indicated the two-centroid clustering to be the most robust with the highest value. In the k ¼ 2 model, all SCC samples were distinctly divided into two classes corresponding to SCC-A and SCC-B samples.
HC typically requires subjective evaluation to define clusters. Depending on the viewpoint, Figure 1b appears to indicate a three-class partition of the SCC samples with a subpartitioning of SCC-A. In the k ¼ 3 NMF partition, however, one of the three classes corresponded roughly to SCC-B, but the remaining two classes did not agree with the subpartitioning of SCC-A from HC, indicating the vulnerability of the three-class partition (Figure 3c ). In brief, by the NMF approach, validity of two-class partition for SCC samples was indicated and the classification was the same as that initially defined (SCC-A and SCC-B).
By the additional independent round of HC and the NMF approach, we were able to confirm the accuracy and robustness of our SCC classification (SCC-A and SCC-B). Since clinical samples were grossly dissected, the expression profiling might have been influenced by the varying amounts of normal tissue included. Therefore, we reviewed the hematoxylin-eosin histology of SCC samples. In normal tissue adjacent to neoplastic cells, there were no distinct characteristics, such as prominent fibrosis, necrosis, or inflammation. It is thus unlikely that our SCC classification depends on nonneoplastic components.
To identify genes differentially expressed between SCC-A and SCC-B, we performed a statistical comparison (Welch's t-test, Bonferoni correction, P ¼ 0.05). This yielded a set of 1590 genes, comprising 91 with expression significantly higher in SCC-A and 1499 genes with expression significantly higher in SCC-B. In the latter, 316 of the 'Different in SCC' 432 genes were included. The top 15 genes are listed in Table 3 . V-akt murine thymoma viral oncogene homolog 2 (AKT2) was selectively upregulated in SCC-B (P ¼ 4.83EÀ09, t-test). AKT2 can contribute to tumor cell progression by mediating phosphoinositide 3-OH kinase-dependent effects on adhesion, motility, invasion, and metastasis (Arboleda et al., 2003) . A recent study showed AKT to promote epithelial mesenchymal transitions in squamous carcinoma cell lines (Grille et al., 2003) . Using EASE analysis, we identified biological process categories that showed significant over-representation. The top 10 over-represented categories for the 91 and the 1499 genes are shown in Table 4 . Cell-proliferation-related categories were mainly over-represented by the 91 genes The top 10 over-represented categories are shown. Numerous other similar categories are not included to reduce redundancy. Significant functional categories are those with a higher ratio of identified genes to all genes on the array for associations with that category, relative to the ratio of total identified genes to all genes for associations with all categories. Association numbers approximate but are not exactly equal to gene numbers in a category. The ratio of associations for that category and the percentage by that ratio was shown in the second column. The analogous ratios for total identified genes are shown in the heading (Total). EASE Score, modified Fisher's exact test P-value Two subclasses of lung squamous cell carcinoma K Inamura et al highly expressed in SCC-A. These included BUB3, a mitotic checkpoint regulator (Taylor et al., 1998) , and ZW10 interactor. For the 1499 genes highly expressed in SCC-B, the over-represented categories were mainly related to differentiated intracellular functions such as the MAPKKK cascade, ceramide metabolism, or regulation of transcription. For example, RASGRP3, involved in the MAPKKK cascade (Rebhun et al., 2000) , or UGCG, a ceramide glucosyltransferase (Ichikawa et al., 1996) , were included. Positive regulation of apoptosis was also an over-represented category and included the deleted in colorectal carcinoma gene (DCC) (Mehlen et al., 1998) and death-associated protein kinase 3 (DAPK3) (Kawai et al., 2003) . We generated Kaplan-Meier survival curves for patients with tumors in the SCC-A and SCC-B groups (Figure 4) and analysis with the log-rank test indicated a tendency for different survival (P ¼ 0.071). The likelihood of survival for 6 years was significantly higher in SCC-B (81.8%) than in SCC-A (40.5%) (P ¼ 0.014, Z-test). For patients with stage I tumors, a similar prognostic difference was recognized. However, statistically there was no significant difference (P ¼ 0.38, logrank test), because of too small sample size (SCC-A, n ¼ 19; SCC-B, n ¼ 8). The likelihood of survival for 6 years was 41.7% in SCC-A and 77.4% in SCC-B (P ¼ 0.17, Z-test). Aside from comparison between SCC-A and SCC-B, we compared prognosis between the NMF partition classes for k ¼ 3-7, and between the two partition classes of SCC-A from HC, there were no significant differences. Between SCC-A and SCC-B, there were no significant correlations for any other clinical and pathological parameters including tumor stage and histological differentiation grade (Table 5) .
Discussion
In this study, we performed an analysis of gene expression profiles for 48 lung SCCs. Firstly, we sought to identify genes whose expression patterns are characteristic of SCC. Groups of genes up-or downregulated in SCC were identified and statistically assessed at the gene function level by using EASE analysis. In upregulated genes, cell-proliferation-related functions were marked and many genes associated with oncogenesis, for example, transcription factor DP-1, an important regulator of the cell cycle (Helin et al., 1993) , were included. Upregulation of many genes encoding proteins with oxidoreductase activity reflects the strong causal relationship between tobacco carcinogens and SCC. Not surprisingly, many of the genes associated with epidermal development were also found upregulated in SCC. The top upregulated genes included several genes encoding epithelial cell-specific markers including cytokeratins. Regarding downregulated genes, Segregation of SCC samples into two groups (SCC-A and SCC-B) was here indicated by the initial analysis and its robustness was confirmed by additional analyses, including the NMF approach. Survival analysis indicated SCC-B to be an SCC subclass with a good prognosis relative to SCC-A. Many genes differentially upregulated in SCC-A have functions associated with cell proliferation or the cell cycle, including BUB3 and ZW10 interactor, which are involved in maintaining the mitotic spindle checkpoint. This contrasts with the report that increased expression of BUB3 and ZW10 is associated with a better prognosis in lung AC cases (Miura et al., 2002) , and suggests pathogenetic differences between SCC and AC. Regarding highly expressed genes in SCC-B, differentiated intracellular functions The top 10 over-represented categories are shown. Numerous other similar categories are not included to reduce redundancy. Significant functional categories are those with a higher ratio of identified genes to all genes on the array for associations with that category, relative to the ratio of total identified genes to all genes for associations with all categories. Association numbers approximate but are not exactly equal to gene numbers in a category. The ratio of associations for that category and the percentage by that ratio was shown in the second column. The analogous ratios for total identified genes are shown in the heading (Total). EASE Score, modified Fisher's exact test P-value Figure 4 Kaplan-Meier survival curves for the 48 SCC patients (SCC-A vs SCC-B) Two subclasses of lung squamous cell carcinoma K Inamura et al were marked in contrast to the 'proliferation signature' of SCC-A. However, upregulation of AKT2 was identified uniquely in SCC-B. This may indicate a SCC-Bspecific mechanism of oncogenesis and suggest that therapeutic inhibition of AKT2 might be a possible strategy for SCC-B control.
It is established that the SCC differentiation grade does not correlate well with prognosis, possibly due to its definition, which depends largely upon the amount of keratinization rather than parameters related to an aggressive nature. Therefore, it is not surprising that our classification of SCC-A and SCC-B demonstrated no significant correlation with the differentiation grade. Furthermore, except for prognosis, our classification had no other significant correlation with clinicopathological parameters. It follows that by expression profiling, we may be able to predict differential prognosis with tumors that are pathologically and clinically indistinguishable.
The need for a new system of classification in SCC is obvious. Whereas prognosis in AC can be quite well predicted on the basis of classical factors such as differentiation grade or the presence of particular histopathological features, notably a micropapillary pattern, similar robust correlations do not exist for SCC. Our present analysis of gene expression patterns, however, allowed division of SCC into two distinct groups with a prognostic difference. This study represents an important step toward the identification of clinically useful classification for lung SCC. Further research will be required to confirm the classification identified here and dissect out its clinical relevance.
Materials and methods

Clinical samples
All clinical samples were collected with ethical committee approval and informed consent from patients undergoing surgery at the Cancer Institute Hospital, Tokyo, Japan, between May 1996 and December 1999. All samples were grossly dissected and snap-frozen in liquid nitrogen within 20 min of removal. Initial diagnosis of each sample from frozen sections was later confirmed by detailed analysis of paraffinembedded sections. We included 30 samples of normal lung from unrelated individuals. Since a simple comparison of gene expression between SCC and normal lung would identify many genes that are commonly regulated across all lung cancers (Virtanen et al., 2002) , we also generated expression profiles for a set of nine well-or moderately differentiated ACs and incorporated these into our analysis. Differentiated ACs were selected because some poorly differentiated ACs can develop transcription profiles that resemble SCCs (Virtanen et al., 2002) . Reference RNA was a mixture of normal lung and lung cancer cell lines as described previously (Virtanen et al., 2002) .
Array design
Each microarray contained 40 386 elements, 39 936 of these being derived from IMAGE cDNA clones purchased from Research Genetics (Huntsville, AL, USA). This was supplemented with 384 proprietary clones and 48 control elements. According to our latest estimate, the array represents 19 877 unique UNIGENE clusters accounting for 10 799 named genes, 2894 other unnamed genes (for example, clones described as hypothetical proteins), and 6184 ESTs. Clones were purchased as sequence verified, but we estimate an error rate of at least 10%. Genes mentioned by name in this paper were resequenced.
Microarray experiments
cRNA was synthesized from total RNA using ampliscribe T7 (Epicenter, Madison, WI, USA) and cDNAs generated with 2 mg aliquots were aminoallyl labeled with Cy5 (sample) or Cy3 (reference), hybridized overnight at 421C in a buffer containing 50% formamide, 5 Â SSC, 0.1% SDS, 0.25 mg/ml human cot1 DNA and 0.125 mg/ml poly-dA and washed to a final stringency of 1 Â SSC at 421C. After washing, slides were immediately scanned on an Axon GenePix 4000B and quantified using Axon GenePix Pro (Axon, Union city, CA, USA).
Microarray data analysis
Data were analysed using GeneSpring (Silicon Genetics, Redwood City, CA, USA) and Matlab (Mathworks, Natick, MA, USA). All data were subjected to intensity-dependent (LOWESS) normalization. Log-transformed data were used for HC and the choice of input genes before NMF approach. For NMF analysis, unlogged data were used because of the non-negativity requirement.
For the initial statistical analysis, we selected genes differentially expressed between the SCC, AC, and normal tissue groups. After each gene was normalized to its median expression value across all 87 samples, Welch's ANOVA with Bonferoni correction (P ¼ 0.05) was performed. This yielded a set of 4689 genes.
For the additional independent round of HC, we selected genes up-or downregulated in SCC samples. For this filtering, normal and SCC samples were separated into two groups. For each group, the expression of each gene was normalized to the median value across all samples. To remove genes that normally vary between individuals and between different sections of lung, we first selected genes that are expressed stably in normal lung. For the 30 normal samples, we selected genes for which we had data in at least 25 of the series and for which the coefficient of variance of log expression ratios was less than 0.6. This yielded a set of 38 924 genes. For each gene, the average log expression ratio of all normal samples (N ave. ) was calculated. These genes were then filtered across the SCC samples passing any gene for which the log expression ratio was more than twice the N ave for any six of the 48 SCC samples or less than half for any six. This process resulted in a set of 3891 genes.
For the NMF approach, we firstly made a choice of input genes. For the 48 SCC samples, we selected genes in which more than 38 of the 48 had an absorption measurement more than 100 in the tumor signal and all 48 samples had more than 100 in the reference channel. This yielded a set of 19 315 genes. From these, we selected examples for which the standard deviation of log expression ratios was more than 0.4. This filtering process resulted in a set of 3344 genes.
NMF analysis was performed in Matlab using codes for NMF divergence reducing equations, as well as for model selection and reordering of the consensus matrices, provided on a website (Brunet et al., 2004 ; http://www.broad.mit.edu/ cancer/). For rank k ¼ 2-7, consensus matrices were obtained by taking the average of over 50 connectivity matrices. Each consensus matrix was reordered by HC using distances derived from consensus clustering matrix entries.
Biological process categorization by gene ontology
We used a new software tool, the EXPRESSION ANALYSIS SYSTEMATIC EXPLORER (Hosack et al., 2003;  http:// david.niaid.nih.gov/david/ease.htm), to assign identified genes to 'GO: Biological Process' categories of the Gene Ontology Consortium (Ashburner et al., 2000 ; http://www.geneontology.org) and for statistical testing (EASE Score, modified Fisher's exact test) for significant coregulation (over-representation) of identified genes within each biological process category.
Analysis of clinical and pathological parameters
Cumulative survival rates were calculated by means of the Kaplan-Meier method and compared by the log-rank test and 
